Get Sample Pages - Asia-Pacific Proteomics Market Size, Share & Growth Report 2032

Asia-Pacific Proteomics Market Research Report: Forecast (2026-2032)

By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarray, Microarray Instrument, Crystallography, Surface Plasma Resonance, Fractionation, Others), By Reage......nt (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Others), By Offering (Core Proteomics Services, Bioinformatics Software & Services), By Application (Drug Discovery, Clinical Diagnostics, Others), By End-User (Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others), and others Read more

Healthcare
Mar 2026
Pages 250
Report Format: PDF, Excel, PPT

Asia-Pacific Proteomics Market Report Key Takeaways:

The Asia-Pacific Proteomics Market size was valued at USD 8.37 billion in 2025 and is projected to grow from USD 9.52 billion in 2026 to USD 20.62 billion by 2032, exhibiting a CAGR of 13.75% during the forecast period.
China holds the largest market share of about 40% in the Asia-Pacific Proteomics Market in 2026.
By technology, the mass spectrometry segment represented a significant share of about 40% in the Asia-Pacific Proteomics Market in 2026.
By application, the drug discovery segment seized a significant share of about 42% in the Asia-Pacific Proteomics Market in 2026.
Leading proteomics companies in the Asia-Pacific Market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, GE HealthCare Technologies Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, Bruker Corporation, Waters Corporation, MRM Proteomics Inc., Luminex Corporation, PerkinElmer, Inc., Olink Proteomics AB, and Others.

Market Insights & Analysis: Asia-Pacific Proteomics Market (2026-32):

The Asia-Pacific Proteomics Market size was valued at around USD 8.37 billion in 2025 and is projected to grow from USD 9.52 billion in 2026 to USD 20.62 billion by 2032. Along with this, the market is estimated to grow at a CAGR of around 13.75% during the forecast period, i.e., 2026-32.

The Asia-Pacific Proteomics Market is projected to expand steadily, driven by the rising burden of chronic diseases and increasing integration of AI and bioinformatics tools, which are enhancing diagnostic capabilities and accelerating advancements in precision medicine.

The region is experiencing a significant rise in non-communicable diseases (NCDs), creating a strong demand for early diagnosis and precision medicine solutions. For instance, approximately 227 million individuals in Asia-Pacific are living with type 2 diabetes , while over 276 million adults in the South-East Asia region alone are affected by diabetes, reflecting a vast patient base that requires ongoing clinical management and sophisticated diagnostic tools .

Beyond diabetes, the prevalence of other chronic conditions further amplifies the need for proteomics-based solutions. For example, more than 294 million people in South-East Asia suffer from hypertension, representing nearly one-third of the adult population, making it one of the most widespread chronic disorders . Additionally, over 104 million individuals are affected by chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma .

The situation is particularly critical in China, where NCDs account for approximately 91% of total deaths , contributing to nearly 9.55 million deaths and 325.9 million disability-adjusted life years (DALYs) in 2023 . These figures underscore the urgent requirement for advanced molecular-level diagnostics and biomarker-driven disease management.

In parallel with the rising disease burden, technological advancements are transforming the proteomics landscape. The integration of artificial intelligence (AI) and bioinformatics tools is enabling rapid and precise analysis of complex proteomic datasets. This has significantly improved protein identification accuracy, accelerated biomarker discovery, and enhanced the efficiency of drug development processes. As a result, healthcare systems are increasingly adopting AI-enabled proteomics to support precision diagnostics and personalized treatment strategies.

Regional organizations such as the Asia Oceania Human Proteome Organization (AOHUPO) are playing a pivotal role in this transition by facilitating training programs, workshops, and collaborative research initiatives. In 2024, several educational and scientific sessions were conducted to strengthen technical expertise and promote cross-border collaboration in proteomics research.

Looking ahead, strong government and institutional investments are expected to further accelerate market growth. Regional healthcare expenditure is projected to reach approximately USD 5.7 trillion by 2030, with significant allocations toward chronic disease management, diagnostics infrastructure, and digital health ecosystems . These investments will enhance accessibility to advanced molecular technologies, including proteomics, across both clinical and research domains.

The convergence of a rapidly increasing chronic disease burden and continuous technological advancements is creating a highly favorable environment for proteomics adoption in the Asia-Pacific. Supported by rising healthcare investments and expanding research collaborations, the market is well-positioned for sustained and robust growth in the coming years.

Asia-Pacific Proteomics Market Recent Developments:

2025: Korea University partnered with Seer Inc. to launch a large-scale proteomics study using AI-driven analytics to develop early cancer diagnostics for young adults. The initiative analyzes over 20,000 samples to identify blood-based biomarkers and improve early detection outcomes.

Asia-Pacific Proteomics Market Scope:

Category	Segments
By Technology	(Spectroscopy, Chromatography, Electrophoresis, Protein Microarray, Microarray Instrument, Crystallography, Surface Plasma Resonance, Fractionation, Others),
By Reagent	(Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Others),
By Offering	(Core Proteomics Services, Bioinformatics Software & Services),
By Application	(Drug Discovery, Clinical Diagnostics, Others),
By End-User	(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others),

Asia-Pacific Proteomics Market Driver:

Rising Burden of Chronic Diseases

The escalating burden of chronic diseases, particularly diabetes and cancer, is a key factor propelling the growth of the proteomics market across Asia-Pacific. For example, data from the World Health Organization indicates that over 77 million adults in India are living with diabetes, with 25 million prediabetic, significantly increasing demand for early detection and biomarker-based diagnostics enabled by advanced proteomics technologies.

The situation is further compounded by the rapid increase in disease prevalence. Recent public health findings suggest that diabetes prevalence in India has nearly doubled, rising from 11% in 2011 to approximately 22% in 2025, reflecting a significant acceleration in metabolic health risks . This sharp rise underscores the urgent requirement for precision medicine approaches, where proteomics plays a critical role in enabling accurate disease stratification and personalized treatment pathways.

In parallel, cancer incidence across the region continues to rise. According to WHO estimates, the South-East Asia region records approximately 2.4 million new cancer cases annually, reinforcing the growing need for advanced molecular diagnostics and targeted therapies . Proteomics technologies are increasingly being utilized to understand tumor heterogeneity, support biomarker discovery, and enhance therapeutic decision-making.

The rapid expansion of the chronic disease burden across the Asia-Pacific is significantly increasing the demand for early, accurate, and personalized diagnostic solutions. As a result, proteomics is emerging as a critical tool in modern healthcare, supporting sustained market growth through its role in precision diagnostics and disease management.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Asia-Pacific Proteomics Market Policies, Regulations, and Product Standards
Asia-Pacific Proteomics Market Trends & Developments
Asia-Pacific Proteomics Market Dynamics
1. Growth Factors
2. Challenges
Asia-Pacific Proteomics Market Hotspot & Opportunities
Asia-Pacific Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
    1. Spectroscopy
      1. Mass Spectroscopy
      2. NMR Spectroscopy
      3. CD Spectroscopy
    2. Chromatography
      1. HPLC Chromatography
      2. Affinity Chromatography
      3. Supercritical Fluid Chromatography
      4. Ion Exchange Chromatography
    3. Electrophoresis
      1. Gel Electrophoresis
      2. Capillary Electrophoresis
    4. Protein Microarray
      1. Biochip
      2. Lab-on-Chip
      3. Protein Chip
    5. Microarray Instrument
      1. Integrated System
      2. Microarray Scanner
      3. Arrayers
    6. Crystallography
    7. Surface Plasma Resonance
    8. Fractionation
    9. Others
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
    1. Immunoassay Reagents
    2. Spectroscopy Reagents
    3. Chromatography Reagents
    4. Protein Microarray Reagents
    5. X-Ray Crystallography Reagents
    6. Electrophoresis Reagents
    7. Protein Fractionation Reagents
    8. Others
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
    1. Core Proteomics Services
      1. Protein Identification
      2. Protein Characterization
      3. Quantitative Proteomic
      4. Protein Purification
      5. Protein Sequencing
      6. Custom Assay
    2. Bioinformatics Software & Services
      1. Bioinformatics Software
      2. Bioinformatics Tools
      3. Bioinformatics Databases
  4. By Application- Market Size & Forecast 2022-2032, USD Million
    1. Drug Discovery
      1. Target Discovery
      2. Lead Identification
      3. Lead Optimization
      4. Preclinical Studies
    2. Clinical Diagnostics
      1. Oncology
      2. Infectious Diseases
      3. Diabetes
      4. Neurological Disorder
      5. Autoimmune Diseases
      6. Cardiovascular Diseases
      7. Others
    3. Others
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
    1. Academic & Research Institutes
    2. Contract Research Organizations
    3. Pharmaceutical & Biotechnology Companies
    4. Others
  6. By Country
    1. China
    2. India
    3. Japan
    4. Singapore
    5. Thailand
    6. Australia
    7. New Zealand
    8. Rest of Asia-Pacific
  7. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
China Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
India Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
Japan Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
Singapore Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
Thailand Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
Australia Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
New Zealand Proteomics Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Technology- Market Size & Forecast 2022-2032, USD Million
  2. By Reagent- Market Size & Forecast 2022-2032, USD Million
  3. By Offering- Market Size & Forecast 2022-2032, USD Million
  4. By Application- Market Size & Forecast 2022-2032, USD Million
  5. By End-User- Market Size & Forecast 2022-2032, USD Million
Asia-Pacific Proteomics Market Key Strategic Imperatives for Success & Growth
Competitive Outlook
1. Company Profiles
  1. Agilent Technologies, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Bio-Rad Laboratories, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Danaher Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  4. GE HealthCare Technologies Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  5. QIAGEN N.V.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Thermo Fisher Scientific Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Illumina, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Merck KGaA
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Promega Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Shimadzu Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Bruker Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Waters Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  13. MRM Proteomics Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Luminex Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  15. PerkinElmer, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Olink Proteomics AB
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  17. Others
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *